Childhood-Onset Leber Hereditary Optic Neuropathy-Clinical and Prognostic Insights.
Barboni Piero, La Morgia Chiara, Cascavilla Maria Lucia, Hong Eun Hee, Battista Marco, Majander Anna, Caporali Leonardo, Starace Vincenzo, Amore Giulia, Renzo Antonio Di
AI Summary
Studying childhood-onset LHON, researchers found children losing vision before age 9 had a better visual prognosis than older children, suggesting a milder disease form.
Abstract
Purpose
To investigate the clinical and molecular genetic features of childhood-onset Leber hereditary optic neuropathy (LHON) to gain a better understanding of the factors influencing the visual outcome in this atypical form of the disease.
Design
Retrospective cohort study.
Methods
We retrospectively included 2 cohorts of patients with LHON with onset of visual loss before the age of 12 years from Italy and the United Kingdom. Ophthalmologic evaluation, including best-corrected visual acuity, orthoptic evaluation, slit-lamp biomicroscopy, visual field testing, and optical coherence tomography, was considered. Patients were classified based on both the age of onset and the pattern of visual loss.
Results
A total of 68 patients were stratified based on the age of onset of visual loss: group 1 (<3 years): 14 patients (20.6%); group 2 (≥3 to <9 years): 27 patients (39.7%); and group 3 (≥9 to ≤12 years): 27 patients (39.7%). Patients in group 2 achieved a better visual outcome than those in group 3. Patients in groups 1 and 2 had better mean deviation on visual field testing than those in group 3. The mean ganglion cell layer thickness on optical coherence tomography in group 2 was higher than those in groups 1 and 3. Patients were also categorized based on the pattern of visual loss as follows: Subacute Bilateral: 54 patients (66.7%); Insidious Bilateral: 14 patients (17.3%); Unilateral: 9 patients (11.1%); and Subclinical Bilateral: 4 patients (4.9%).
Conclusions
Children who lose vision from LHON before the age of 9 years have a better visual prognosis than those who become affected in later years, likely representing a "form frustre" of the disease.
MeSH Terms
Shields Classification
Key Concepts4
Children who lose vision from Leber hereditary optic neuropathy (LHON) before the age of 9 years have a better visual prognosis than those who become affected in later years, likely representing a "form frustre" of the disease.
In a cohort of 68 patients with childhood-onset Leber hereditary optic neuropathy (LHON), patients with onset of visual loss between 3 and <9 years (group 2, 27 patients, 39.7%) achieved a better visual outcome than those with onset between 9 and ≤12 years (group 3, 27 patients, 39.7%).
In a cohort of 68 patients with childhood-onset Leber hereditary optic neuropathy (LHON), patients with onset of visual loss before 3 years (group 1, 14 patients, 20.6%) and between 3 and <9 years (group 2, 27 patients, 39.7%) had better mean deviation on visual field testing than those with onset between 9 and ≤12 years (group 3, 27 patients, 39.7%).
In a cohort of 68 patients with childhood-onset Leber hereditary optic neuropathy (LHON), the mean ganglion cell layer thickness on optical coherence tomography in patients with onset of visual loss between 3 and <9 years (group 2, 27 patients, 39.7%) was higher than in those with onset before 3 years (group 1, 14 patients, 20.6%) and between 9 and ≤12 years (group 3, 27 patients, 39.7%).
Related Articles5
Predictors of Final Visual Outcome in Patients With Leber Hereditary Optic Neuropathy Treated With Lenadogene Nolparvovec Gene Therapy.
Clinical TrialMitochondrial retinopathies and optic neuropathies: The impact of retinal imaging on modern understanding of pathogenesis, diagnosis, and management.
ReviewOphthalmic Findings in the KIF1A-Associated Neurologic Disorder (KAND).
Cross-Sectional StudyOptic Nerve Head Morphological Variation in Craniosynostosis: A Cohort Study.
Cohort StudyCharacterization of Ocular Morphology in Col4a3-/- Mice as a Murine Model for Alport Syndrome.
Basic ScienceIs this article assigned to the wrong chapter(s)? Let us know.